NeuroX1

The new standard in computational neuroscience

NeuroX1 was founded in 2024, is headquartered in Austin, United States, lists 1–10 employees, and has $1.8M in recorded funding across 5 rounds.

Headquarters
Austin, Texas
Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$1.8M
Last Round
Series CJun 2024
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 3 investors for this company. The full record is or through the API.

About

NeuroX1 is a computational neuroscience and drug discovery company building a platform to identify drivers of neurodegenerative and neurological diseases using proprietary generative AI algorithms. The platform employs deep reinforcement learning to generate novel drug compounds tailored to specific therapeutic parameters, targeting conditions such as Alzheimer's and ALS. Founded in 2021 by Maxwell Dordevic, Conner Myers, and Lucas Myers in Austin, Texas. The company raised $1.83M across multiple seed rounds from Drive Capital, Trousdale Ventures, and others. NeuroX1 participated in Techstars Knoxville.

Summary

NeuroX1 is an Artificial Intelligence company based in Austin, United States, founded in 2024. It lists 1–10 employees. It has raised $1.8M in total across 5 rounds, most recently a Series C round in Jun 2024. Investors include Capital Factory, Techstars and Drive Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJun 2024

Sign up to see all 5 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NeuroX1 on Indexed.vc
<a href="https://indexed.vc/companies/neurox1"><img src="https://indexed.vc/api/badge/company/neurox1" alt="NeuroX1 on Indexed.vc" width="260" height="76" /></a>